- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 451
Anti-allergen developer DBV goes public
The corporate-backed company, which is developing treatments for peanut and milk allergies, secured $92.6m after raising approximately $50m in venture funding.
Oct 28, 2014Sky Solar clears way for $150m IPO
The China-based solar power producer will float in the US after setting a range if between $10 and $12m for the offering.
Oct 28, 2014Ooyala acquires video ad platform Videoplaza
Online video publishing and analytics company Ooyala has acquired video ad management platform Videoplaza for an undisclosed amount, allowing Qualcomm to exit.
Oct 23, 2014Digital Guardian strengthens with Armor5 acquisition
Mobile security start-up Armor5 has been acquired by data security company Digital Guardian for an undisclosed amount as it expands its focus to mobile data.
Oct 21, 2014Atara goes public in $55m IPO
The Amgen and Celgene-backed pharmaceutical company raised the cash after pulling in $72m in venture funding over two years.
Oct 20, 2014KDDI invests $113m in funding and acquisitions
The telecommunications company has bought two Japan-based companies and invested in a further five.
Oct 20, 2014SoftBank catches Bertelsmann and AMC-backed DramaFever
Korea-focused online video platform DramaFever has been acquired by SoftBank's internet media subsidiary for an undisclosed amount after raising $7.5m in equity.
Oct 16, 2014Hunan Juewei seeks nourishment from IPO
The Fosun-backed snack food retailer is set to issue 90 million shares in a Chinese initial public offering, three years after raising $42m.
Oct 15, 2014EMC buys cloud infrastructure company Cloudscaling
Juniper Networks and Seagate Technology exited the software provider in a sub-$50m deal, made after Cloudscaling had raised about $15m in equity.
Oct 15, 2014Alzheimer's drug developer Probiodrug sets IPO terms
Alzheimer's drug developer Probiodrug, the backers of which include Biogen Idec, has set the range for a proposed initial public offering in the Netherlands.
Oct 14, 2014About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


